Eloxx Pharmaceuticals, Inc.

ELOX · OTC
Analyze with AI
9/30/2023
6/30/2023
3/31/2023
12/31/2022
Assets
Cash & Equivalents$4,775$4,331$4,904$19,207
Short-Term Investments$0$0$0$0
Receivables$0$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$854$1,051$1,499$922
Total Curr. Assets$5,629$5,382$6,403$20,129
Property Plant & Equip (Net)$413$611$797$994
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$0$0$0$0
Total NC Assets$413$611$797$994
Other Assets$0$0$0$0
Total Assets$6,042$5,993$7,200$21,123
Liabilities
Payables$3,134$3,121$2,434$3,020
Short-Term Debt$3,134$2,768$2,203$4,692
Tax Payable$0$0$0$0
Deferred Revenue$12,966$12,535$12,535$12,535
Other Curr. Liab.$4,232$2,827$2,288$2,844
Total Curr. Liab.$23,466$21,251$19,460$23,091
LT Debt$2,624$3,338$4,033$8,692
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$2,624$3,338$4,033$8,692
Other Liabilities$0$0$0$0
Cap. Leases$318$496$673$847
Total Liabilities$26,090$24,589$23,493$31,783
Equity
Pref Stock$0$0$0$0
Common Stock$31$25$22$22
Retained Earnings-$288,551-$284,959-$280,618-$274,388
AOCI$0$0$0$0
Other Equity$268,472$266,338$264,303$263,706
Total Equity-$20,048-$18,596-$16,293-$10,660
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$6,042$5,993$7,200$21,123
Net Debt$983$1,775$1,332-$5,823